BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Prognosis
110 results:

  • 1. Undifferentiated Embryonal Sarcoma of the liver with Epithelioid Features: A Case Report of an Exceptional Histological Heterogeneity among Rare Diseases.
    Kersik A; Bracchetti G; Bonomi A; Bovo G; Serena Cuttin M; Germini A; Gjoni E; Granieri S; Cotsoglou C
    Ann Ital Chir; 2024; 95(2):119-125. PubMed ID: 38684493
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Controlling Nutritional Status (CONUT) Score is Associated with Overall Survival in Patients with Hepatocellular Carcinoma Treated with Conventional Transcatheter Arterial Chemoembolization: A Propensity Score Matched Analysis.
    Deng Z; Zhang W; Peng J; Gao L; Zhang C; Lei K; Gong J; Xiong B
    Cardiovasc Intervent Radiol; 2024 May; 47(5):592-603. PubMed ID: 38605220
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Treating rare tumors with liver transplantation.
    Melehy A; Agopian V
    Curr Opin Organ Transplant; 2024 Feb; 29(1):30-36. PubMed ID: 37851086
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. MRI-Based Radiomics and Deep Learning in Biological Characteristics and prognosis of Hepatocellular Carcinoma: Opportunities and Challenges.
    Xia T; Zhao B; Li B; Lei Y; Song Y; Wang Y; Tang T; Ju S
    J Magn Reson Imaging; 2024 Mar; 59(3):767-783. PubMed ID: 37647155
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Based on network pharmacology and experiments to explore the underlying mechanism of Mahonia bealei (Fortune) Carrière for treating alcoholic hepatocellular carcinoma.
    Zhang N; Zhu Y; Zhang X; Yang K; Yang X; An M; Tian C; Li J
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116919. PubMed ID: 37453621
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Small bowel neuroendocrine tumours - casting the net wide.
    Chetcuti Zammit S; Sidhu R
    Curr Opin Gastroenterol; 2023 May; 39(3):200-210. PubMed ID: 37144538
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Advances in the genetics of nonalcoholic fatty liver disease.
    Ajmera V; Loomba R
    Curr Opin Gastroenterol; 2023 May; 39(3):150-155. PubMed ID: 37144531
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
    Singh I; Singh A
    Curr Oncol Rep; 2023 Jun; 25(6):539-547. PubMed ID: 36928826
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data.
    Li M; Gao X; Wang X
    Front Immunol; 2023; 14():1090838. PubMed ID: 36911742
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Nutritional support in liver disease - an updated systematic review.
    Koretz RL
    Curr Opin Gastroenterol; 2023 Mar; 39(2):115-124. PubMed ID: 36821460
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical risk factors for patients with ruptured hepatoblastoma in children: a retrospective study from a single center in China.
    Chang S; Yang S; Yang W; Qin H; Cheng H; Chang X; Zhu Z; Yin J; Ren Q; Yu S; Wang H
    Pediatr Surg Int; 2023 Jan; 39(1):76. PubMed ID: 36622431
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic Markers after Hepatic Function Impairment in Patients with Pancreatic Adenocarcinoma.
    Buyukkor M; Tay F; Karacin C; Duran AO
    J Coll Physicians Surg Pak; 2023 Jan; 33(1):32-36. PubMed ID: 36597232
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Comprehensive Analysis of Prognostic Factors in Advanced Gastric cancer Patients Treated with Chemotherapy.
    Cavdar E; Iriagac Y; Avci O; Seber ES
    J Coll Physicians Surg Pak; 2022 Nov; 32(11):1420-1424. PubMed ID: 36377008
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. liver transplantation and portal vein tumour thrombus: futile enterprise?
    Bhangui P
    Curr Opin Organ Transplant; 2022 Aug; 27(4):312-319. PubMed ID: 36354257
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?
    Wang Y; Strazzabosco M; Madoff DC
    Curr Oncol Rep; 2022 Dec; 24(12):1741-1750. PubMed ID: 36255606
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Treatment of metastatic uveal melanoma in 2022: improved treatment regimens and improved prognosis.
    Reichstein D; Brock A; Lietman C; McKean M
    Curr Opin Ophthalmol; 2022 Nov; 33(6):585-590. PubMed ID: 36094043
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Metabolic syndrome, obesity and cancer risk.
    Belladelli F; Montorsi F; Martini A
    Curr Opin Urol; 2022 Nov; 32(6):594-597. PubMed ID: 36081396
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives.
    Hochreuter MY; Dall M; Treebak JT; Barrès R
    Mol Metab; 2022 Nov; 65():101581. PubMed ID: 36028120
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The C-Reactive Protein to Albumin Ratio Is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: A Large Cohort Study.
    Li J; Yang S; Li Y; Li C; Xia Y; Zhu S; Xia J
    Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1295-1303. PubMed ID: 35835873
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731.
    Vasudevan SA; Meyers RL; Finegold MJ; López-Terrada D; Ranganathan S; Dunn SP; Langham MR; McGahren ED; Tiao GM; Weldon CB; Malogolowkin MH; Krailo MD; Piao J; Randazzo J; Towbin AJ; BethMcCarville M; O'Neill AF; Furman WL; Rodriguez-Galindo C; Katzenstein HM
    J Pediatr Surg; 2022 Oct; 57(10):251-256. PubMed ID: 35810020
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.